Skip to main content
Radiotherapy

Radiotherapy

Immunotherapy plus radiotherapy benefits metastatic lung cancer patients

17 Jul 2019 Tami Freeman
Radiotherapy plus immunotherapy
Treating metastatic non-small cell lung cancer patients with immunotherapy plus ablative therapy increases progression-free survival. (Courtesy: Penn Medicine)
The past decade has witnessed the advent of modern immunotherapy. Monoclonal antibodies that target

You’ve reached the limit of what you can view on Physics World without registering

If you already have an account on Physics World, then please sign in to continue reading

If you do not yet have an account, please register so you can

  • Access more than 20 years of online content
  • Choose which e-mail newsletters you would like to receive
Copyright © 2024 by IOP Publishing Ltd and individual contributors